Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy
- 1 March 1998
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 48 (2) , 107-116
- https://doi.org/10.1023/a:1005933815809
Abstract
Experimental laboratory data suggest that tumour growth is a balance between apoptosis and proliferation and that suppression of drug-induced apoptosis by oncogenes such as bcl-2 may be an important...Keywords
This publication has 26 references indexed in Scilit:
- Primary chemotherapy in surgically resectable breast cancerCA: A Cancer Journal for Clinicians, 1995
- Changes in biological markers after primary chemotherapy for breast cancersInternational Journal of Cancer, 1995
- The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinomaBritish Journal of Cancer, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor statusBritish Journal of Cancer, 1993
- A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA.Journal of Histochemistry & Cytochemistry, 1993
- Apoptosis induced by anticancer drugsCancer and Metastasis Reviews, 1992
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- Cell Death: The Significance of ApoptosisPublished by Elsevier ,1980